Uncommon Therapeutics | Gene Therapy | Standout | Standout

Uncommon Therapeutics

A Disease Focused Biotech, Building Multiple Billion Dollar Drugs

San Francisco

2 employees

Gene Therapy

Pre-seed · $500K

Website

About Uncommon Therapeutics

Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.

Company details

Team Size2

LocationSan Francisco

IndustryGene Therapy

Funding

Total raised

$500K

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies Docs

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

Last stage

Pre-seed

Investors

Y Combinator

Pioneer Fund

EEthos Fund

RRoar Ventures

SSingularity Capital

Founders

Ryan Lim

Biotech entrepreneur and biomedical scientist specializing in modeling neurological disorders using stem cells, in vivo models, and computational biology to drive breakthroughs in neurological diseases

Noah Auerhahn

Serial tech entrepreneur; bootstrapped first company and sold to Rakuten for $15M; raised over $75M for second venture (Robin Healthcare). Pivoted to biotech after his daughter was diagnosed with Rett Syndrome in 2021.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.